TickerGuard
Buy Day today: Poor (44) Weak market breadth · major macro event coming up
OMER

Omeros Corporation

Healthcare · Biotechnology

20.70$ -1.5% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Cash Flow

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Cash Flow OMER
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
-10,768.8% -482.7% -123.8% -55.9% -347.3% -53.7% -135.6% -121.2%
60.5% 1.5% 0.7% 0.8% 3.2% 1.6% 2.2% 1.5%
1,654.5% 70.9% 32.6% 19.6% 39.2% 12.3% 20.2% 19.5%
1,951.6% 88.4% 49.6% 26.0% 59.5% 12.3% 23.2% -323.6%
889.2% -16.8% -14.9% -0.3% 14.4% -0.4% 10.3% -15.6%
5.2% 1.8% 0.3% 0.5% 1.9% 0.3% 0.4% 0.3%
1,142.3% -152.5% -39.3% -58.0% 84.2% -3.0% -90.8% 214.0%
0.0% 0.0% 0.0% 0.0%
7,004.5% 606.5% 99.0% 116.4% 22.5% 55.3% 133.7% 9.0%
2,129.7% 36.2% 66.1% -0.7% 359.9% 1.3% 125.5% 0.3%
9,435.4% 642.7% 165.1% 115.7% 271.4% 54.3% 236.5% 7.0%
-191.1% 7.5% 2.1% 1.8% 8.3% -2.5% 10.0% 99.8%
-10,774.0% -484.5% -124.1% -56.4% -349.2% -54.0% -136.0% -121.5%

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?